Literature DB >> 9365999

Sexuality, reproduction, and family planning in women with schizophrenia.

L J Miller1.   

Abstract

This article reviews data about how schizophrenia affects sexuality, pregnancy, the puerperium, parenting, and family planning. Women with schizophrenia have high rates of coerced sex, sexual risk behavior, and unwanted pregnancies. High rates of obstetric complications and custody loss increase morbidity for women and their offspring. Since untreated psychosis increases these problems, the risks of withholding pharmacotherapy must be weighed against the risks of prescribing medications during pregnancy. The puerperium is a time when women are especially vulnerable to exacerbations of schizophrenia. Mothers with schizophrenia may have a reduced ability to read children's cues, and they often have weak social support networks. Their children may be more difficult to raise than other children. Parenting rehabilitation can address some of these problems. Often, women with schizophrenia who are sexually active and do not wish to become pregnant do not use contraception. Incorporating family planning measures into mental health care delivery systems may reduce unwanted pregnancies.

Entities:  

Keywords:  Americas; Behavior; Child Care; Child Rearing; Contraception; Developed Countries; Diseases; Drugs; Education; Family Planning; Health; Literature Review; Mental Disorders; North America; Northern America; Organization And Administration; Personality; Pregnancy; Program Activities; Programs; Psychological Factors; Reproduction; Reproductive Health; Sex Education; Sexuality; Treatment; United States

Mesh:

Substances:

Year:  1997        PMID: 9365999     DOI: 10.1093/schbul/23.4.623

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  16 in total

Review 1.  Effects of antipsychotics on the unborn child: what is known and how should this influence prescribing?

Authors:  H B Pinkofsky
Journal:  Paediatr Drugs       Date:  2000 Mar-Apr       Impact factor: 3.022

2.  Best practice in maternity and mental health services? A service user's perspective.

Authors:  Joanna R Fox
Journal:  Schizophr Bull       Date:  2012-02-21       Impact factor: 9.306

Review 3.  Perinatal Risks and Childhood Premorbid Indicators of Later Psychosis: Next Steps for Early Psychosocial Interventions.

Authors:  Cindy H Liu; Matcheri S Keshavan; Ed Tronick; Larry J Seidman
Journal:  Schizophr Bull       Date:  2015-04-22       Impact factor: 9.306

4.  Family history of psychosis as a predictor or protective factor of social maladjustment in a population at clinical high risk for psychosis.

Authors:  S Lucy Poe; Kelly E Gill; Gary Brucato; Cheryl M Corcoran; Ragy R Girgis
Journal:  Psychiatry Res       Date:  2014-07-14       Impact factor: 3.222

5.  Antipsychotic-induced somnolence in mothers with schizophrenia.

Authors:  Mary V Seeman
Journal:  Psychiatr Q       Date:  2012-03

Review 6.  Second-generation antipsychotics: is there evidence for sex differences in pharmacokinetic and adverse effect profiles?

Authors:  Wolfgang Aichhorn; Alexandra B Whitworth; Elisabeth M Weiss; Josef Marksteiner
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

7.  Supported Parenting to Meet the Needs and Concerns of Mothers with Severe Mental Illness.

Authors:  Daryn H David; Thomas Styron; Larry Davidson
Journal:  Am J Psychiatr Rehabil       Date:  2011-04

8.  Living with schizophrenia in India: gender perspectives.

Authors:  Santosh Loganathan; R Srinivasa Murthy
Journal:  Transcult Psychiatry       Date:  2011-11

Review 9.  The potential impact of the recovery movement on family interventions for schizophrenia: opportunities and obstacles.

Authors:  Shirley M Glynn; Amy N Cohen; Lisa B Dixon; Noosha Niv
Journal:  Schizophr Bull       Date:  2006-03-08       Impact factor: 9.306

10.  Motherhood in women with serious mental illness.

Authors:  Nikole Benders-Hadi; Mary Barber; Mary Jane Alexander
Journal:  Psychiatr Q       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.